HassaneMohamedZarourMD
Dermatology • Pittsburgh, PAProfessor, Medicine and Dermatology, University of Pittsburgh School of Medicine
Dr. Zarour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5117 Centre Ave
Research Pavilion, Suite 1.32a
Pittsburgh, PA 15213Phone+1 412-623-3272- Is this information wrong?
Education & Training
University of the Mediterranean Faculty of MedicineClass of 1991, Dermatology and Cutaneous Oncology
Certifications & Licensure
PA State Medical License 2003 - 2024
Clinical Trials
- CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors Start of enrollment: 2009 Jan 01
- NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma Start of enrollment: 2014 Jan 24
- Treatment of Advanced Melanoma With MK-3475 and Peginterferon Start of enrollment: 2014 Jul 24
Publications & Presentations
PubMed
- 2 citationsMelanoma and microbiota: Current understanding and future directions.Bertrand Routy, Tanisha Jackson, Laura Mählmann, Christina K Baumgartner, Martin Blaser, Allyson Byrd, Nathalie Corvaia, Kasey Couts, Diwakar Davar, Lisa Derosa, Howar...> ;Cancer Cell. 2024 Jan 8
- Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.Ryan C Augustin, Sarah Newman, Aofei Li, Marion Joy, Maureen Lyons, Mary P Pham, Peter Lucas, Katelyn Smith, Cindy Sander, Brian Isett, Diwakar Davar, Yana G Najjar, H...> ;Journal for Immunotherapy of Cancer. 2023 Oct 1
- 87 citationsDietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment.Mackenzie J Bender, Alex C McPherson, Catherine M Phelps, Surya P Pandey, Colin R Laughlin, Jake H Shapira, Luzmariel Medina Sanchez, Mohit Rana, Tanner G Richie, Tahl...> ;Cell. 2023 Apr 27
- Join now to see all
Press Mentions
Fecal Microbiota Transplants May Improve Resistance to Melanoma ImmunotherapyOctober 13th, 2021- Fecal Microbiota Transplant Changes Melanoma Immunotherapy Non-Responders to RespondersFebruary 5th, 2021
Vedanta Biosciences Announces Initiation of First-in-Patient Study of Immuno-Oncology Candidate VE800 in Combination with Bristol-Myers Squibb's Opdivo® (Nivolumab)December 10th, 2019- Join now to see all
Grant Support
- Reversing Melanoma-Induced T Cell DysfunctionNational Cancer Institute2011–2012
- Optimization Of Melanoma Vaccines With T-Helper EpitopesNational Cancer Institute2009–2012
- Melanoma Vaccines With Peptides, Protein And AdjuvantNational Cancer Institute2005–2009
- Optimization Of Melanoma Vaccine With T Helper EpitopeNational Cancer Institute2002–2007
- Promune W/Wo Chemo Trtmt Stage III B/C/Iv MelanomaNational Center For Research Resources2005
- Pilot Immun W/Cpg 7909 Or Multi-Epitope Immunogen Nyeso-1National Center For Research Resources2005
Hospital Affiliations
- Shadyside CampusPittsburgh, Pennsylvania
UPMC Magee-Womens HospitalPittsburgh, Pennsylvania
UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
